These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28056332)

  • 1. [Aspirin use in patients with atherosclerotic cardiovascular disease: the 2016 Chinese expert consensus statement].
    ; ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):68-80. PubMed ID: 28056332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Aspirin for Prevention of Recurrent Atherosclerotic Cardiovascular Disease Among Adults — 20 States and the District of Columbia, 2013.
    Fang J; George MG; Hong Y; Loustalot F
    MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(27):733-7. PubMed ID: 26182190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
    Wang Y; Chen W; Wang Y
    Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke: Secondary prevention of ischemic events.
    Morris JG; Carter EL; Martin SA
    J Fam Pract; 2017 Jul; 66(7):420-427. PubMed ID: 28700757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
    Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
    Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Ischemic Stroke: Strategies for Prevention.
    Oza R; Rundell K; Garcellano M
    Am Fam Physician; 2017 Oct; 96(7):436-440. PubMed ID: 29094912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
    Liao JK
    Circulation; 2007 Mar; 115(12):1615-21. PubMed ID: 17389280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Stroke; 2017 Sep; 48(9):2610-2613. PubMed ID: 28701574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
    Poredos P; Jezovnik MK
    Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances.
    Carlin S; de Vries TAC; Budaj A; Eikelboom J
    Kardiol Pol; 2022; 80(12):1200-1210. PubMed ID: 36601884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early dual therapy for Chinese adults with TIA.
    BMJ; 2013 Jul; 347():f4197. PubMed ID: 23823995
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].
    Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.
    Liu F; Tantry US; Gurbel PA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1149-65. PubMed ID: 25873127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for Primary Atherosclerotic Cardiovascular Disease Prevention as Baseline Risk Increases: A Meta-Regression Analysis.
    Nudy M; Cooper J; Ghahramani M; Ruzieh M; Mandrola J; Foy AJ
    Am J Med; 2020 Sep; 133(9):1056-1064. PubMed ID: 32445718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
    Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS;
    Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.